Abstract
Cases description This is a retrospective study, based on analysis of data from patients with previous adverse drug reactions admitted to the Allergy and Clinical Immunology Division of both the University of Messina and the University of Bari in the last 4 years. We observed five patients: four of them (two males and two females) with a well documented history of tranexamic acid hypersensitivity reactions and one female who showed a positive response to an intradermal challenge test with tranexamic acid. Conclusions Although the risk of immunogenic and severe allergic reactions to tranexamic acid is significantly lower than those associated with administration of other drugs, our experience points out that adverse reactions to tranexamic acid can occur. This drug may be responsible for a wide and various spectrum of hypersensitivity reactions characterized by different pathogenetic mechanisms (immunologic and non-immunologic). Etamsylate was a well tolerated alternative drug to tranexamic acid in all examined patients.
This is a preview of subscription content, log in via an institution to check access.
References
Shedden C, Highet AS. Delayed pressure urticaria controlled by tranexamic acid. Clin Exp Dermatol. 2006;31(2):295–6.
Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs. 2003;63(13):1417–33.
Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57(6):1005–32.
Odabas AR, Cetinkaya R, Selcuk Y, Kaya H, Coskun U. Tranexamic-acid-induced acute renal cortical necrosis in a patient with haemophilia A. Nephrol Dial Transplant. 2001;16(1):189–90.
Lucas-Polomeni MM, Delaval Y, Menestret P, Delaval P, Ecoffey C. A case of anaphylactic shock with tranexamique acid. Ann Fr Anesth Reanim. 2004;23(6):607–9.
Carriòn-Carriòn C, del Pozo-Losada J, Gutierrez-Ramos R, de Lucas-Laguna R, García-Diaz B, Casado-Jiménez M, Esperanza-Jiménez Caballero ME. Bullous eruption induced by tranexamic acid. Ann Pharm. 1994;28(11):1305–6.
Kavanagh GM, Samsom JE, Harrison P, Warwick JA, Peachey RD. Tranexamic acid (Cyklokapron)-induced fixed-drug eruption. Br J Dermatol. 1993;128(2):229–30.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.
Brockow K, Romano A. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des. 2008;14(27):2778–91.
Levy YH. Hemostatic agents and their safety. J Cardiothorac Vasc Anesth. 1999;13(4 Suppl.1):6–11.
Garay RP, Chiavaroli C, Hannaert P. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent. Am J Ther. 2006;13(3):236–47.
Acknowledgments
We thank Dr. Francesco Cimino for pharmacological assistance, Dr. Stefania Isola for clinical assistance and Dr. Joseph Lipari for editing assistance.
Funding
No financial support was provided for this study.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imbesi, S., Nettis, E., Minciullo, P.L. et al. Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions. Pharm World Sci 32, 416–419 (2010). https://doi.org/10.1007/s11096-010-9415-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-010-9415-8